Sunil Kapila
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sunil Kapila has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Andrew H. Jheon
Department of Orthodontics and Dentofacial Orthopedics, University of Pittsburgh, School of Dental Medicine, Pittsburgh, PA, USA
3 shared publications Aida Mohammadi
UCLA Section of Orthodontics, UCLA School of Dentistry University of California at Los Angeles Los Angeles California USA
2 shared publicationsBhushan Kharbikar
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), San Francisco, CA, United States
2 shared publications- Darnell L. Cuylear
Department of Orofacial Sciences, University of California San Francisco, School of Dentistry, San Francisco, CA, USA
2 shared publications Galateia J. Kazakia
Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), San Francisco, CA, United States
2 shared publications- Tejal A. Desai
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, USA
2 shared publications
Latest Publications
- Open Access
- 27 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 575-588
Osteocyte-Intrinsic MMP13 exacerbates injury-induced temporomandibular joint osteoarthritis
- 27 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 575-588
Open AccessOsteocyte-Intrinsic MMP13 exacerbates injury-induced temporomandibular joint osteoarthritis
- Open Access
- 3 October 2025
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (S1) , S81-S90
Differentially Expressed Salivary miRNAs in Temporomandibular Disorders
Objective: Temporomandibular disorders (TMDs) are heterogeneous conditions of unclear aetiology involving the temporomandibular joint, masticatory muscles and neural tissues. Limited understanding of their pathogenesis hampers accurate diagnosis and targeted treatment. Therefore, this study aimed to identify salivary microRNA (miRNA) signatures associated with TMDs to support future diagnostic, therapeutic and prognostic applications. Materials and Methods: Unstimulated cell‐free saliva (5 mL) was collected from 9 adult female TMD subjects (using Diagnostic Criteria/TMD) and eight healthy female controls of similar ages. Total RNA was extracted, small RNA libraries were prepared, and sequencing was performed using Illumina NovaSeq 6000. Reads were aligned to the human genome (GRCh38) via STAR. Differential expression analysis was conducted using DESeq2, followed by functional enrichment via miEAA 2.1. Results: A total of 187 salivary miRNAs were significantly differentially expressed between TMD and control groups (adjusted p < 0.05; log2‐fold change > +1 or < −1), with 125 upregulated and 62 downregulated in TMD subjects. Several differentially expressed miRNAs were linked to the negative regulation of cadherin‐mediated cell–cell adhesion, neurogenesis and chemokine production. Some overlapped with miRNAs implicated in rheumatoid arthritis and osteoarthritis, suggesting shared mechanisms. While no clear association was found between miRNA and TMD phenotypes, 5 miRNAs were strongly ( R = 0.67–0.77) and significantly ( p < 0.05) correlated with pain intensity and chronic pain grade. Conclusions: Salivary miRNA profiling offers promise as a non‐invasive diagnostic tool for TMDs, with the potential to uncover molecular endotypes and disease mechanisms not evident through clinical evaluation. Future studies with larger, more diverse cohorts are needed to validate these findings and assess their clinical utility.
- 3 October 2025
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (S1) , S81-S90
Open AccessDifferentially Expressed Salivary miRNAs in Temporomandibular Disorders
Objective: Temporomandibular disorders (TMDs) are heterogeneous conditions of unclear aetiology involving the temporomandibular joint, masticatory muscles and neural tissues. Limited understanding of their pathogenesis hampers accurate diagnosis and targeted treatment. Therefore, this study aimed to identify salivary microRNA (miRNA) signatures associated with TMDs to support future diagnostic, therapeutic and prognostic applications. Materials and Methods: Unstimulated cell‐free saliva (5 mL) was collected from 9 adult female TMD subjects (using Diagnostic Criteria/TMD) and eight healthy female controls of similar ages. Total RNA was extracted, small RNA libraries were prepared, and sequencing was performed using Illumina NovaSeq 6000. Reads were aligned to the human genome (GRCh38) via STAR. Differential expression analysis was conducted using DESeq2, followed by functional enrichment via miEAA 2.1. Results: A total of 187 salivary miRNAs were significantly differentially expressed between TMD and control groups (adjusted p < 0.05; log2‐fold change > +1 or < −1), with 125 upregulated and 62 downregulated in TMD subjects. Several differentially expressed miRNAs were linked to the negative regulation of cadherin‐mediated cell–cell adhesion, neurogenesis and chemokine production. Some overlapped with miRNAs implicated in rheumatoid arthritis and osteoarthritis, suggesting shared mechanisms. While no clear association was found between miRNA and TMD phenotypes, 5 miRNAs were strongly ( R = 0.67–0.77) and significantly ( p < 0.05) correlated with pain intensity and chronic pain grade. Conclusions: Salivary miRNA profiling offers promise as a non‐invasive diagnostic tool for TMDs, with the potential to uncover molecular endotypes and disease mechanisms not evident through clinical evaluation. Future studies with larger, more diverse cohorts are needed to validate these findings and assess their clinical utility.
- Open Access
- 15 September 2025
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (S1) , S110-S117
Sensory and Sympathetic Nerve Localization in Mouse Temporomandibular Joint and Knee Joint Neuro‐Musculoskeletal Tissues
Objective: Sympathetic‐sensory coupling is increasingly implicated in joint homeostasis and disease. Towards the long‐term goal of deciphering its role in temporomandibular disorders (TMDs), we characterised the spatial relationships of sympathetic and sensory nerves and their receptors in the mouse temporomandibular joint (TMJ) and trigeminal ganglion (TG), using the knee joint for comparison. Materials and Methods: RNAscope was used for localisation of sympathetic nerve markers tyrosine hydroxylase ( Th ) and adrenergic receptor alpha 2a ( Adrα2a ); and brain‐derived neurotrophic factor ( Bdnf ) and its receptor neurotrophic receptor tyrosine kinase 2 ( Ntrk2 ) that stimulate sympathetic nerve growth. Sensory marker calcitonin gene‐related peptide (CGRP) was detected through immunofluorescence. Results: Th , Adrα2a , Bdnf and Ntrk2 were expressed in the TMJ and knee joint tissues, including condylar and disc cartilages, muscles and bone marrow. CGRP+ sensory neurons were abundant in the TG and, to a lesser extent, in TMJ and knee tissues, where they were often located near Th ‐ or Adrα2a ‐expressing sympathetic cells. Some CGRP+ neurons in the TG also co‐expressed Adrα2a . Conclusion: Our findings reveal the presence of sympathetic and sensory nerves within the TMJ, knee joint and TG, with these nerves often located near each other. Along with the presence of Adrα2a on CGRP+ sensory fibres, this suggests sympathetic‐sensory coupling and potential crosstalk in physiologic and pathologic responses. Expression of Bdnf and Ntrk2 in the TMJ and knee implicates this neurotrophin signalling in modulating sympathetic activity via neural sprouting. Further studies will clarify the functional contributions of this neurological architecture to tissue homeostasis, disease and pain.
- 15 September 2025
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 28 (S1) , S110-S117
Open AccessSensory and Sympathetic Nerve Localization in Mouse Temporomandibular Joint and Knee Joint Neuro‐Musculoskeletal Tissues
Objective: Sympathetic‐sensory coupling is increasingly implicated in joint homeostasis and disease. Towards the long‐term goal of deciphering its role in temporomandibular disorders (TMDs), we characterised the spatial relationships of sympathetic and sensory nerves and their receptors in the mouse temporomandibular joint (TMJ) and trigeminal ganglion (TG), using the knee joint for comparison. Materials and Methods: RNAscope was used for localisation of sympathetic nerve markers tyrosine hydroxylase ( Th ) and adrenergic receptor alpha 2a ( Adrα2a ); and brain‐derived neurotrophic factor ( Bdnf ) and its receptor neurotrophic receptor tyrosine kinase 2 ( Ntrk2 ) that stimulate sympathetic nerve growth. Sensory marker calcitonin gene‐related peptide (CGRP) was detected through immunofluorescence. Results: Th , Adrα2a , Bdnf and Ntrk2 were expressed in the TMJ and knee joint tissues, including condylar and disc cartilages, muscles and bone marrow. CGRP+ sensory neurons were abundant in the TG and, to a lesser extent, in TMJ and knee tissues, where they were often located near Th ‐ or Adrα2a ‐expressing sympathetic cells. Some CGRP+ neurons in the TG also co‐expressed Adrα2a . Conclusion: Our findings reveal the presence of sympathetic and sensory nerves within the TMJ, knee joint and TG, with these nerves often located near each other. Along with the presence of Adrα2a on CGRP+ sensory fibres, this suggests sympathetic‐sensory coupling and potential crosstalk in physiologic and pathologic responses. Expression of Bdnf and Ntrk2 in the TMJ and knee implicates this neurotrophin signalling in modulating sympathetic activity via neural sprouting. Further studies will clarify the functional contributions of this neurological architecture to tissue homeostasis, disease and pain.
- Open Access
- 14 November 2024
- Published by Elsevier in Biomaterials
- Vol. 315, 122965
Calcium phosphate nanoclusters modify periodontium remodeling and minimize orthodontic relapse
- 14 November 2024
- Published by Elsevier in Biomaterials
- Vol. 315, 122965
Open AccessCalcium phosphate nanoclusters modify periodontium remodeling and minimize orthodontic relapse
- Open Access
Calcium phosphate nanoclusters modify periodontium remodeling and minimize orthodontic relapse
Orthodontic relapse is one of the most prevalent concerns of orthodontic therapy. Relapse results in patients’ teeth reverting towards their pretreatment positions, which increases the susceptibility to functional problems, dental disease, and substantially increases the financial burden for retreatment. This phenomenon is thought to be induced by rapid remodeling of the periodontal ligament (PDL) in the early stages and poor bone quality in the later stages. Current therapies, including fixed or removable retainers and fiberotomies, have limitations with patient compliance and invasiveness. Approaches using biocompatible biomaterials, such as calcium phosphate polymer-induced liquid precursors (PILP), is an ideal translational approach for minimizing orthodontic relapse. Here, post-orthodontic relapse is reduced after a single injection of high concentration PILP (HC-PILP) nanoclusters by altering PDL remodeling in the early stage of relapse and improving trabecular bone quality in the later phase. HC-PILP nanoclusters are achieved by using high molecular weight poly aspartic acid (PASP, 14 kDa) and poly acrylic acid (PAA, 450 kDa), which resulted in a stable solution of high calcium and phosphate concentrations without premature precipitation. In vitro results show that HC-PILP nanoclusters prevented collagen type-I mineralization, which is essential for the tooth-periodontal ligament (PDL)-bone interphase. In vivo experiments show that the PILP nanoclusters minimize relapse and improve the trabecular bone quality in the late stages of relapse. Interestingly, PILP nanoclusters also altered the remodeling of the PDL collagen during the early stages of relapse. Further in vitro experiments showed that PILP nanoclusters alter the fibrillogenesis of collagen type-I by impacting the protein secondary structure. These findings propose a novel approach for treating orthodontic relapse and provide additional insight into the PILP nanocluster’s structure and properties on collagenous structure repair.
Open AccessCalcium phosphate nanoclusters modify periodontium remodeling and minimize orthodontic relapse
Orthodontic relapse is one of the most prevalent concerns of orthodontic therapy. Relapse results in patients’ teeth reverting towards their pretreatment positions, which increases the susceptibility to functional problems, dental disease, and substantially increases the financial burden for retreatment. This phenomenon is thought to be induced by rapid remodeling of the periodontal ligament (PDL) in the early stages and poor bone quality in the later stages. Current therapies, including fixed or removable retainers and fiberotomies, have limitations with patient compliance and invasiveness. Approaches using biocompatible biomaterials, such as calcium phosphate polymer-induced liquid precursors (PILP), is an ideal translational approach for minimizing orthodontic relapse. Here, post-orthodontic relapse is reduced after a single injection of high concentration PILP (HC-PILP) nanoclusters by altering PDL remodeling in the early stage of relapse and improving trabecular bone quality in the later phase. HC-PILP nanoclusters are achieved by using high molecular weight poly aspartic acid (PASP, 14 kDa) and poly acrylic acid (PAA, 450 kDa), which resulted in a stable solution of high calcium and phosphate concentrations without premature precipitation. In vitro results show that HC-PILP nanoclusters prevented collagen type-I mineralization, which is essential for the tooth-periodontal ligament (PDL)-bone interphase. In vivo experiments show that the PILP nanoclusters minimize relapse and improve the trabecular bone quality in the late stages of relapse. Interestingly, PILP nanoclusters also altered the remodeling of the PDL collagen during the early stages of relapse. Further in vitro experiments showed that PILP nanoclusters alter the fibrillogenesis of collagen type-I by impacting the protein secondary structure. These findings propose a novel approach for treating orthodontic relapse and provide additional insight into the PILP nanocluster’s structure and properties on collagenous structure repair.
- Open Access
- 15 November 2023
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 26 (S1) , 8-19
Connecting the dots towards precision orthodontics
Precision orthodontics entails the use of personalized clinical, biological, social and environmental knowledge of each patient for deep individualized clinical phenotyping and diagnosis combined with the delivery of care using advanced customized devices, technologies and biologics. From its historical origins as a mechanotherapy and materials driven profession, the most recent advances in orthodontics in the past three decades have been propelled by technological innovations including volumetric and surface 3D imaging and printing, advances in software that facilitate the derivation of diagnostic details, enhanced personalization of treatment plans and fabrication of custom appliances. Still, the use of these diagnostic and therapeutic technologies is largely phenotype driven, focusing mainly on facial/skeletal morphology and tooth positions. Future advances in orthodontics will involve comprehensive understanding of an individual's biology through omics, a field of biology that involves large‐scale rapid analyses of DNA, mRNA, proteins and other biological regulators from a cell, tissue or organism. Such understanding will define individual biological attributes that will impact diagnosis, treatment decisions, risk assessment and prognostics of therapy. Equally important are the advances in artificial intelligence (AI) and machine learning, and its applications in orthodontics. AI is already being used to perform validation of approaches for diagnostic purposes such as landmark identification, cephalometric tracings, diagnosis of pathologies and facial phenotyping from radiographs and/or photographs. Other areas for future discoveries and utilization of AI will include clinical decision support, precision orthodontics, payer decisions and risk prediction. The synergies between deep 3D phenotyping and advances in materials, omics and AI will propel the technological and omics era towards achieving the goal of delivering optimized and predictable precision orthodontics.
- 15 November 2023
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 26 (S1) , 8-19
Open AccessConnecting the dots towards precision orthodontics
Precision orthodontics entails the use of personalized clinical, biological, social and environmental knowledge of each patient for deep individualized clinical phenotyping and diagnosis combined with the delivery of care using advanced customized devices, technologies and biologics. From its historical origins as a mechanotherapy and materials driven profession, the most recent advances in orthodontics in the past three decades have been propelled by technological innovations including volumetric and surface 3D imaging and printing, advances in software that facilitate the derivation of diagnostic details, enhanced personalization of treatment plans and fabrication of custom appliances. Still, the use of these diagnostic and therapeutic technologies is largely phenotype driven, focusing mainly on facial/skeletal morphology and tooth positions. Future advances in orthodontics will involve comprehensive understanding of an individual's biology through omics, a field of biology that involves large‐scale rapid analyses of DNA, mRNA, proteins and other biological regulators from a cell, tissue or organism. Such understanding will define individual biological attributes that will impact diagnosis, treatment decisions, risk assessment and prognostics of therapy. Equally important are the advances in artificial intelligence (AI) and machine learning, and its applications in orthodontics. AI is already being used to perform validation of approaches for diagnostic purposes such as landmark identification, cephalometric tracings, diagnosis of pathologies and facial phenotyping from radiographs and/or photographs. Other areas for future discoveries and utilization of AI will include clinical decision support, precision orthodontics, payer decisions and risk prediction. The synergies between deep 3D phenotyping and advances in materials, omics and AI will propel the technological and omics era towards achieving the goal of delivering optimized and predictable precision orthodontics.
- 14 June 2023
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 26 (S1) , 4-7
Preface to the 9th Biennial COAST Conference: Harnessing Technology and Biomedicine for Personalized Orthodontics
Objective: The Consortium on Orthodontic Advances in Science and Technology (COAST) convened for its 9th biennial conference titled ‘Harnessing Technology and Biomedicine for Personalized Orthodontics’ to explore cutting‐edge craniofacial research towards building the foundations for precision care in orthodontics. Setting and Sample Population: Seventy‐five faculty, scholars, private practitioners, industry, residents and students met at the UCLA Arrowhead Lodge on 6–9 November 2022 for networking, scientific presentations and facilitated discussions. Thirty‐three speakers provided state‐of‐the‐art, evidence‐based scientific and perspective updates in craniofacial and orthodontic‐related fields. The overall format included an Education Innovation Award Faculty Development Career Enrichment (FaCE) workshop focused on faculty career development, three lunch and learns, keynote or short talks and poster presentations. Material and Methods: The 2022 COAST Conference was organized thematically to include (a) genes, cells and environment in craniofacial development and abnormalities; (b) precision modulation of tooth movement, retention and facial growth; (c) applications of artificial intelligence in craniofacial health; (d) precision approaches to Sleep Medicine, OSA and TMJ therapies; and (e) precision technologies and appliances. Results: The collective advances in orthodontics and science represented in the manuscripts of this issue fulfil our goal of laying solid foundations for personalized orthodontics. Participants elevated the need for stronger industry‐academic research partnerships to leverage knowledge gained from large datasets with treatment approaches and outcomes; systematizing the potential of big data including through multi‐omics and artificial intelligence approaches; refining the genotype: phenotype correlation to create biotechnology that will rescue inherited dental and craniofacial defects; evolving studies of tooth movement, sleep apnoea and TMD treatment to accurately measure dysfunction and treatment successes; and maximizing the integration of newer orthodontic devices and digital workflows. Conclusions: Technological advances combined with those in biomedicine and machine learning are rapidly changing the delivery of health care including that in orthodontics. These advances promise to lead to enhanced customization, efficiencies and outcomes of patient care in routine orthodontic problems and in severe craniofacial problems, OSA and TMD.
- 14 June 2023
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 26 (S1) , 4-7
Preface to the 9th Biennial COAST Conference: Harnessing Technology and Biomedicine for Personalized Orthodontics
Objective: The Consortium on Orthodontic Advances in Science and Technology (COAST) convened for its 9th biennial conference titled ‘Harnessing Technology and Biomedicine for Personalized Orthodontics’ to explore cutting‐edge craniofacial research towards building the foundations for precision care in orthodontics. Setting and Sample Population: Seventy‐five faculty, scholars, private practitioners, industry, residents and students met at the UCLA Arrowhead Lodge on 6–9 November 2022 for networking, scientific presentations and facilitated discussions. Thirty‐three speakers provided state‐of‐the‐art, evidence‐based scientific and perspective updates in craniofacial and orthodontic‐related fields. The overall format included an Education Innovation Award Faculty Development Career Enrichment (FaCE) workshop focused on faculty career development, three lunch and learns, keynote or short talks and poster presentations. Material and Methods: The 2022 COAST Conference was organized thematically to include (a) genes, cells and environment in craniofacial development and abnormalities; (b) precision modulation of tooth movement, retention and facial growth; (c) applications of artificial intelligence in craniofacial health; (d) precision approaches to Sleep Medicine, OSA and TMJ therapies; and (e) precision technologies and appliances. Results: The collective advances in orthodontics and science represented in the manuscripts of this issue fulfil our goal of laying solid foundations for personalized orthodontics. Participants elevated the need for stronger industry‐academic research partnerships to leverage knowledge gained from large datasets with treatment approaches and outcomes; systematizing the potential of big data including through multi‐omics and artificial intelligence approaches; refining the genotype: phenotype correlation to create biotechnology that will rescue inherited dental and craniofacial defects; evolving studies of tooth movement, sleep apnoea and TMD treatment to accurately measure dysfunction and treatment successes; and maximizing the integration of newer orthodontic devices and digital workflows. Conclusions: Technological advances combined with those in biomedicine and machine learning are rapidly changing the delivery of health care including that in orthodontics. These advances promise to lead to enhanced customization, efficiencies and outcomes of patient care in routine orthodontic problems and in severe craniofacial problems, OSA and TMD.
- Open Access
- 1 April 2022
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 26 (7) , 5019-5027
Morphologic and histologic characterization of sheep and porcine TMJ as large animal models for tissue engineering applications
Objective: The aim of this study was to compare and characterize the structural and ultrastructural organization of the temporomandibular joint (TMJ) between two large animal models for use in the development of tissue engineering strategies. Materials and methods: Whole TMJs from sheep and pigs were evaluated with micro-computed tomography (μCT) for morphology and quantitative analyses of bone parameters. Histological examination was performed on the TMJ disc and its attachments to investigate regional distribution of collagen, elastin, and glycosaminoglycans (GAGs). Results: μCT analyses demonstrate higher bone mineral density (BMD) in the temporal fossa compared to the mandibular condyle in both species, with this variable being significantly higher in sheep than pig. Quantitative morphometry of the trabecular condyle reveals no statistical differences between the species. Histology demonstrates similar structural organization of collagen and elastin between species. Elastin staining was nearly twofold greater in sheep than in the pig disc. Finally, Safranin-O staining for GAGs in the TMJ disc was localized to the intermediate zone in the sheep but was absent from the porcine disc. Conclusions: Our findings show some important differences in the pig and sheep TMJ μCT variables and histology and composition of the disc and discal attachment. These disparities likely reflect differences in masticatory and TMJ functional loading patterns between the two species and provide insights into large animal models towards human applications. Clinical relevance: As with the established pig model, the sheep is a suitable large animal model for TMJ research such as regenerative strategies, with specific considerations for design parameters appropriate for human-analog applications.
- 1 April 2022
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 26 (7) , 5019-5027
Open AccessMorphologic and histologic characterization of sheep and porcine TMJ as large animal models for tissue engineering applications
Objective: The aim of this study was to compare and characterize the structural and ultrastructural organization of the temporomandibular joint (TMJ) between two large animal models for use in the development of tissue engineering strategies. Materials and methods: Whole TMJs from sheep and pigs were evaluated with micro-computed tomography (μCT) for morphology and quantitative analyses of bone parameters. Histological examination was performed on the TMJ disc and its attachments to investigate regional distribution of collagen, elastin, and glycosaminoglycans (GAGs). Results: μCT analyses demonstrate higher bone mineral density (BMD) in the temporal fossa compared to the mandibular condyle in both species, with this variable being significantly higher in sheep than pig. Quantitative morphometry of the trabecular condyle reveals no statistical differences between the species. Histology demonstrates similar structural organization of collagen and elastin between species. Elastin staining was nearly twofold greater in sheep than in the pig disc. Finally, Safranin-O staining for GAGs in the TMJ disc was localized to the intermediate zone in the sheep but was absent from the porcine disc. Conclusions: Our findings show some important differences in the pig and sheep TMJ μCT variables and histology and composition of the disc and discal attachment. These disparities likely reflect differences in masticatory and TMJ functional loading patterns between the two species and provide insights into large animal models towards human applications. Clinical relevance: As with the established pig model, the sheep is a suitable large animal model for TMJ research such as regenerative strategies, with specific considerations for design parameters appropriate for human-analog applications.
- Open Access
The Significance of Utilizing A Corticotomy on Periodontal and Orthodontic Outcomes: A Systematic Review and Meta-Analysis
Purpose: This systematic review compares the clinical and radiographic outcomes for patients who received only a corticotomy or periodontal accelerated osteogenic orthodontics (PAOO) with those who received a conventional orthodontic treatment. Methods: An electronic search of four databases and a hand search of peer-reviewed journals for relevant articles published in English between January 1980 and June 2021 were performed. Human clinical trials of ≥10 patients treated with a corticotomy or PAOO with radiographic and/or clinical outcomes were included. Meta-analyses were performed to analyze the weighted mean difference (WMD) and confidence interval (CI) for the recorded variables. Results: Twelve articles were included in the quantitative analysis. The meta-analysis revealed a localized corticotomy distal to the canine can significantly increase canine distalization (WMD = 1.15 mm, 95% CI = 0.18–2.12 mm, p = 0.02) compared to a conventional orthodontic treatment. In addition, PAOO also showed a significant gain of buccal bone thickness (WMD = 0.43 mm, 95% CI = 0.09–0.78 mm, p = 0.01) and an improvement of bone density (WMD = 32.86, 95% CI = 11.83–53.89, p = 0.002) compared to the corticotomy group. Conclusion: Based on the findings of the meta-analyses, the localized use of a corticotomy can significantly increase the amount of canine distalization during orthodontic treatment. Additionally, the use of a corticotomy as a part of a PAOO procedure significantly increases the rate of orthodontic tooth movement and it is accompanied by an increased buccal bone thickness and bone density compared to patients undergoing a conventional orthodontic treatment.
Open AccessThe Significance of Utilizing A Corticotomy on Periodontal and Orthodontic Outcomes: A Systematic Review and Meta-Analysis
Purpose: This systematic review compares the clinical and radiographic outcomes for patients who received only a corticotomy or periodontal accelerated osteogenic orthodontics (PAOO) with those who received a conventional orthodontic treatment. Methods: An electronic search of four databases and a hand search of peer-reviewed journals for relevant articles published in English between January 1980 and June 2021 were performed. Human clinical trials of ≥10 patients treated with a corticotomy or PAOO with radiographic and/or clinical outcomes were included. Meta-analyses were performed to analyze the weighted mean difference (WMD) and confidence interval (CI) for the recorded variables. Results: Twelve articles were included in the quantitative analysis. The meta-analysis revealed a localized corticotomy distal to the canine can significantly increase canine distalization (WMD = 1.15 mm, 95% CI = 0.18–2.12 mm, p = 0.02) compared to a conventional orthodontic treatment. In addition, PAOO also showed a significant gain of buccal bone thickness (WMD = 0.43 mm, 95% CI = 0.09–0.78 mm, p = 0.01) and an improvement of bone density (WMD = 32.86, 95% CI = 11.83–53.89, p = 0.002) compared to the corticotomy group. Conclusion: Based on the findings of the meta-analyses, the localized use of a corticotomy can significantly increase the amount of canine distalization during orthodontic treatment. Additionally, the use of a corticotomy as a part of a PAOO procedure significantly increases the rate of orthodontic tooth movement and it is accompanied by an increased buccal bone thickness and bone density compared to patients undergoing a conventional orthodontic treatment.
- 9 August 2021
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 25 (2) , 183-191
IGF‐1 TMJ injections enhance mandibular growth and bone quality in juvenile rats
Objectives Dentofacial orthopaedic treatment of mandibular hypoplasia has unpredictable skeletal outcomes. Although several biomodulators including insulin-like growth factor 1 (IGF-1) are known to contribute to chondrocyte proliferation, their efficacy in modulating mandibular growth has not been validated. The aim of this study was to determine the effect of locally delivered IGF-1 on mandibular growth and condylar bone quality/quantity in juvenile rats. Setting and sample population Institutional vivarium using twenty-four 35-day-old male Sprague-Dawley rats. Methods PBS or 40 µg/kg (low-dose) IGF-1 or 80 µg/kg (high-dose) IGF-1 was injected bilaterally into the temporomandibular joints of the rats at weekly intervals for four weeks. Cephalometric and micro-computed tomography measurements were used to determine mandibular dimensions. Bone and tissue mineral density, volume fraction and mineral content were determined, and serum IGF-1 concentrations assayed. Results Intra-articular administration of high-dose IGF-1 contributed to a significant 6%-12% increase in mandibular body and condylar length compared to control and low-dose IGF-1-treated animals. Additionally, IGF-1 treatment resulted in a significant decrease in the angulation of the lower incisors to mandibular plane. Condylar bone volume, bone volume fraction, mineral content and mineral density were significantly increased with high-dose IGF-1 relative to control and low-dose IGF-1 groups. Serum IGF-1 levels were similar between all groups confirming limited systemic exposure to the locally administered IGF-1. Conclusion Local administration of high-dose 80 µg/kg IGF-1 enhances mandibular growth and condylar bone quality and quantity in growing rats. The findings have implications for modulating mandibular growth and potentially enhancing condylar bone health and integrity.
- 9 August 2021
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 25 (2) , 183-191
IGF‐1 TMJ injections enhance mandibular growth and bone quality in juvenile rats
Objectives Dentofacial orthopaedic treatment of mandibular hypoplasia has unpredictable skeletal outcomes. Although several biomodulators including insulin-like growth factor 1 (IGF-1) are known to contribute to chondrocyte proliferation, their efficacy in modulating mandibular growth has not been validated. The aim of this study was to determine the effect of locally delivered IGF-1 on mandibular growth and condylar bone quality/quantity in juvenile rats. Setting and sample population Institutional vivarium using twenty-four 35-day-old male Sprague-Dawley rats. Methods PBS or 40 µg/kg (low-dose) IGF-1 or 80 µg/kg (high-dose) IGF-1 was injected bilaterally into the temporomandibular joints of the rats at weekly intervals for four weeks. Cephalometric and micro-computed tomography measurements were used to determine mandibular dimensions. Bone and tissue mineral density, volume fraction and mineral content were determined, and serum IGF-1 concentrations assayed. Results Intra-articular administration of high-dose IGF-1 contributed to a significant 6%-12% increase in mandibular body and condylar length compared to control and low-dose IGF-1-treated animals. Additionally, IGF-1 treatment resulted in a significant decrease in the angulation of the lower incisors to mandibular plane. Condylar bone volume, bone volume fraction, mineral content and mineral density were significantly increased with high-dose IGF-1 relative to control and low-dose IGF-1 groups. Serum IGF-1 levels were similar between all groups confirming limited systemic exposure to the locally administered IGF-1. Conclusion Local administration of high-dose 80 µg/kg IGF-1 enhances mandibular growth and condylar bone quality and quantity in growing rats. The findings have implications for modulating mandibular growth and potentially enhancing condylar bone health and integrity.